News & Insights

Cases & Deals

King & Spalding Advises Insulin-Related Digital Health Apps/Software Company


King & Spalding advised a client developing digital health apps intended to be used with insulin products regarding FDA’s regulatory and legal framework, and how to minimize associated regulatory and legal risks.